KDP has been the topic of a number of other reports. Guggenheim reaffirmed a “hold” rating on shares of Keurig Dr Pepper in a report on Friday, September 27th. Royal Bank of Canada set a $31.00 target price on shares of Keurig Dr Pepper and gave the company a “buy” rating in a report on Friday, August 9th. SunTrust Banks set a $35.00 target price on shares of Keurig Dr Pepper and gave the company a “buy” rating in a report on Friday, September 27th. Morgan Stanley set a $24.00 target price on shares of Keurig Dr Pepper and gave the company a “sell” rating in a report on Friday, August 9th. Finally, Bank of America boosted their price objective on shares of Keurig Dr Pepper from $30.00 to $33.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the company. Keurig Dr Pepper currently has an average rating of “Buy” and a consensus target price of $30.49.
Shares of Keurig Dr Pepper stock opened at $30.52 on Tuesday. The firm’s fifty day simple moving average is $28.98 and its 200-day simple moving average is $28.42. The stock has a market capitalization of $42.96 billion, a price-to-earnings ratio of 29.35, a PEG ratio of 1.66 and a beta of 0.46. Keurig Dr Pepper has a 12 month low of $24.52 and a 12 month high of $32.00. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.35 and a quick ratio of 0.23.
In other news, Director Robert S. Singer acquired 3,500 shares of the company’s stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $29.39 per share, with a total value of $102,865.00. Following the purchase, the director now owns 53,001 shares of the company’s stock, valued at approximately $1,557,699.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Mary Beth Denooyer acquired 6,000 shares of the company’s stock in a transaction on Tuesday, September 10th. The stock was purchased at an average cost of $26.97 per share, for a total transaction of $161,820.00. Insiders acquired a total of 82,500 shares of company stock worth $2,313,255 over the last three months. 0.44% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in KDP. MRA Associates USA LLC acquired a new position in Keurig Dr Pepper in the 2nd quarter valued at $25,000. Fulcrum Equity Management acquired a new position in Keurig Dr Pepper in the 3rd quarter valued at $30,000. Pearl River Capital LLC acquired a new position in Keurig Dr Pepper in the 2nd quarter valued at $31,000. Steward Partners Investment Advisory LLC acquired a new position in Keurig Dr Pepper in the 2nd quarter valued at $42,000. Finally, Quadrant Capital Group LLC increased its stake in Keurig Dr Pepper by 221.3% in the 3rd quarter. Quadrant Capital Group LLC now owns 1,809 shares of the company’s stock valued at $46,000 after buying an additional 1,246 shares during the period. 20.53% of the stock is currently owned by institutional investors.
About Keurig Dr Pepper
Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.
Featured Article: Outstanding Shares and The Effect on Share Price
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.